(19)
(11) EP 4 824 278 A1

(12)

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24905073.3

(22) Date of filing: 16.12.2024
(51) International Patent Classification (IPC): 
C12Q 1/6806(2018.01)
G01N 33/574(2006.01)
C12N 5/09(2010.01)
(52) Cooperative Patent Classification (CPC):
C12N 5/0693; C12Q 1/6886; G01N 2800/245; G01N 33/5758
(86) International application number:
PCT/US2024/060376
(87) International publication number:
WO 2025/129182 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 14.12.2023 US 202363610118 P

(71) Applicant: Rarecells Inc.
New York, NY 10032 (US)

(72) Inventor:
  • PATERLINI, Patrizia
    75015 Paris (FR)

(74) Representative: SONN Patentanwälte GmbH & Co KG 
Riemergasse 14
1010 Wien
1010 Wien (AT)

   


(54) SCREENING SAMPLES FOR SUBCLINICAL INDICIA OF CANCER